NEUBASE THERAPEUTICS INC stock forecast: down to 0.44 USD NBSE stock price prognosis

STOCK

Forecast for Wed 10 Jul 2024 price 0.52

NEUBASE THERAPEUTICS INC stock price forecast for further price development down to -56.90% (time horizon: 1 day) and price target of 0.44 USD. Short-term (time horizon: 2 weeks) NEUBASE THERAPEUTICS INC share price prediction for 2024-07-10 with daily closed price projections

Key Facts

Symbol NBSE 

ISIN US64132K1025 

CUSIP 64132K102


Currency USD


Category Pharmaceutical Preparations

Forecast price change %

Relative Strength Index (RSI)

Finance numbers

Earnings per share -0.89


On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

This is termed the “central dogma” of biology. We are developing “anti-gene” therapies. Anti-genes are similar, but distinct, from antisense oligonucleotides (ASOs). Stability of peptide nucleic acids in human serum and cellular extracts. doi: 10.1016/0006-2952(94)90171-6. Erratum in: Mol Ther Nucleic Acids. PMID: 26440599; PMCID: PMC4881755. There are currently no approved treatments available to slow the progression of HD. Any agency or judicial enforcement action could have a material adverse effect on us. & A sponsor may also voluntarily propose a REMS as part of the NDA submission. Once adopted, REMS are subject to periodic assessment and modification. & This summary does not address all of the risks that we face. Several of our employees work remotely. In particular, third-party payors may limit the covered indications. The negotiation process in some countries can exceed 12 months. Our financial statements have been prepared in accordance with U.S. GAAP. These formulations may be covered by intellectual property rights held by others. Such challenges may result in loss of exclusivity or freedom to operate. Moreover, the length of the extension could be less than we request. We and the individuals dispute these claims and intend to defend the matter vigorously. The defendants dispute the claims raised in the Wheby Action.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1173281/000110465920139139/0001104659-20-139139.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 30.00/100

Institutional ownership list is based on filling form information

Holding name Date Amount
Point72 Asset Management, L.P. 2022-12-31 1250000
PRELUDE CAPITAL MANAGEMENT, LLC 2023-03-31 311000
VANGUARD GROUP INC 2023-03-31 376758
Newbridge Financial Services Group, Inc. 2022-12-31 250
PERKINS CAPITAL MANAGEMENT INC 2022-12-31 99000

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2023-02-28 19719 Long
Fidelity Concord Street Trust 2023-02-28 143724 Long
SCHWAB CAPITAL TRUST 2023-01-31 29716 Long
Fidelity Concord Street Trust 2023-05-31 27182 Long
Fidelity Concord Street Trust 2023-05-31 28508 Long

Insider trading for NEUBASE THERAPEUTICS INC

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1991925 Symetryx Corp 2023-09-18 SALE Reject Reject 0 0


Bollinger Bollinger Bands for NEUBASE THERAPEUTICS INC can provide the information where the market is moving based on price information.


NEUBASE THERAPEUTICS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.



Converting prices to returns NEUBASE THERAPEUTICS INC.


On-Balance Volume information for NEUBASE THERAPEUTICS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.



Accumulation / Distribution (A/D) indicator information for NEUBASE THERAPEUTICS INC. The indicator identify divergences between price and volume flow.


Aroon Oscillator information for NEUBASE THERAPEUTICS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.


Average Directional Index (ADX) information for NEUBASE THERAPEUTICS INC. The index can be used to identify the strengh of a trend.


Moving Average Convergence Divergence (MACD) for NEUBASE THERAPEUTICS INC. The indicator helps to predict trend direction and the momentum of the trend.


Stochastic Oscillator as momentum indicator for NEUBASE THERAPEUTICS INC. The indicator is useful for identifying overbought and oversold levels.


Relative Strength Index (RSI) for NEUBASE THERAPEUTICS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].


Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.


The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.


The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.


Moving Average Crossover


52W High 52W Low Market Cap

Similar shares


NEUBASE THERAPEUTICS INC on Nasdaq

NEUBASE THERAPEUTICS INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2024-06-10 0.44 2024-05-15 07:31
2024-06-11 0.45 2024-05-15 07:31
2024-06-07 0.44 2024-05-15 07:31
2024-06-05 0.43 2024-05-15 07:31
2024-05-30 0.42 2024-05-15 07:31
2024-05-29 0.41 2024-05-15 07:31
2024-06-03 0.42 2024-05-15 07:31
2024-06-04 0.43 2024-05-15 07:31
2024-05-31 0.42 2024-05-15 07:31
2024-05-27 0.41 2024-05-15 07:31
2024-05-28 0.41 2024-05-15 07:31
2024-06-06 0.44 2024-05-15 07:31
2024-06-17 0.46 2024-05-15 07:31
2024-06-18 0.47 2024-05-15 07:31
2024-06-12 0.45 2024-05-15 07:31
2024-06-13 0.45 2024-05-15 07:31
2024-06-20 0.47 2024-05-15 07:31
2024-06-14 0.46 2024-05-15 07:31
2024-06-19 0.47 2024-05-15 07:31
2024-06-24 0.48 2024-05-15 07:31
2024-06-25 0.48 2024-05-15 07:31
2024-07-05 0.51 2024-05-15 07:31
2024-07-10 0.52 2024-05-15 07:31
2024-06-21 0.48 2024-05-15 07:31
2024-06-26 0.49 2024-05-15 07:31
2024-07-03 0.51 2024-05-15 07:31
2024-07-01 0.50 2024-05-15 07:31
2024-07-02 0.50 2024-05-15 07:31
2024-06-28 0.50 2024-05-15 07:31
2024-07-04 0.51 2024-05-15 07:31
2024-07-08 0.52 2024-05-15 07:31
2024-07-09 0.52 2024-05-15 07:31
2024-06-27 0.49 2024-05-15 07:31

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.